Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • For Subscribers
    • For Advertisers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in

Search

  • Advanced search
Molecular Pharmacology
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
Molecular Pharmacology

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • For Subscribers
    • For Advertisers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Visit molpharm on Facebook
  • Follow molpharm on Twitter
  • Follow molpharm on LinkedIn
Rapid CommunicationAccelerated Communication

Mdr1 Limits CYP3A Metabolism in Vivo

Lu-Bin Lan, James T. Dalton and Erin G. Schuetz
Molecular Pharmacology October 2000, 58 (4) 863-869; DOI: https://doi.org/10.1124/mol.58.4.863
Lu-Bin Lan
1Department of Pharmaceutical Sciences, St. Jude Children's Research Hospital, Memphis, Tennessee (L.-B.L., E.G.S.); and 2Department of Pharmaceutical Sciences, University of Tennessee, Memphis, Tennessee (J.T.D.)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
James T. Dalton
1Department of Pharmaceutical Sciences, St. Jude Children's Research Hospital, Memphis, Tennessee (L.-B.L., E.G.S.); and 2Department of Pharmaceutical Sciences, University of Tennessee, Memphis, Tennessee (J.T.D.)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Erin G. Schuetz
1Department of Pharmaceutical Sciences, St. Jude Children's Research Hospital, Memphis, Tennessee (L.-B.L., E.G.S.); and 2Department of Pharmaceutical Sciences, University of Tennessee, Memphis, Tennessee (J.T.D.)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF
Loading

Log in using your username and password

Forgot your user name or password?

Pay Per Article - You may access this article (from the computer you are currently using) for 1 day for US$35.00

Regain Access - You can regain access to a recent Pay per Article purchase if your access period has not yet expired.

PreviousNext
Back to top

In this issue

Molecular Pharmacology: 58 (4)
Molecular Pharmacology
Vol. 58, Issue 4
1 Oct 2000
  • Table of Contents
  • About the Cover
  • Index by author
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Molecular Pharmacology article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Mdr1 Limits CYP3A Metabolism in Vivo
(Your Name) has forwarded a page to you from Molecular Pharmacology
(Your Name) thought you would be interested in this article in Molecular Pharmacology.
Citation Tools
Rapid CommunicationAccelerated Communication

Mdr1 Limits CYP3A Metabolism in Vivo

Lu-Bin Lan, James T. Dalton and Erin G. Schuetz
Molecular Pharmacology October 1, 2000, 58 (4) 863-869; DOI: https://doi.org/10.1124/mol.58.4.863

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Rapid CommunicationAccelerated Communication

Mdr1 Limits CYP3A Metabolism in Vivo

Lu-Bin Lan, James T. Dalton and Erin G. Schuetz
Molecular Pharmacology October 1, 2000, 58 (4) 863-869; DOI: https://doi.org/10.1124/mol.58.4.863
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Materials and Methods
    • Results
    • Discussion
    • Acknowledgment
    • Footnotes
    • Abbreviations
    • References
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • Structure of the Diltiazem Receptor Site on Calcium Channels
  • 5-HT and Sleep
  • Effect of Constitutive Activity on Potentiation
Show more Accelerated Communication

Similar Articles

  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About Molecular Pharmacology
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Journal of Pharmacology and Experimental Therapeutics
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0111 (Online)

Copyright © 2019 by the American Society for Pharmacology and Experimental Therapeutics